tocophersolan has been researched along with andrographolide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bera, T; Das, S; Halder, A; Mondal, S; Mukherjee, A; Roy, P | 1 |
| Chen, L; Chen, T; Di, L; Fu, T; Li, J; Qiao, H; Rui, T; Wang, J | 1 |
2 other study(ies) available for tocophersolan and andrographolide
| Article | Year |
|---|---|
In vitro susceptibilities of wild and drug resistant leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacy.
Topics: Animals; Biological Transport; Capsules; Diterpenes; Drug Interactions; Drug Resistance; Drug Stability; Female; Kinetics; Lactic Acid; Leishmania donovani; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2013 |
Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Transport; Caco-2 Cells; Diterpenes; Humans; Interleukin-1; Male; Mice; Nanoparticles; Nanotechnology; Nitric Oxide; Particle Size; Rats, Sprague-Dawley; Sodium Dodecyl Sulfate; Solubility; Superoxide Dismutase; Suspensions; Time Factors; Tumor Necrosis Factor-alpha; Vitamin E | 2017 |